Standard Chemical & Pharmaceutical Co. Ltd. (TPE:1720)
56.00
+0.10 (0.18%)
Oct 23, 2025, 2:36 PM CST
TPE:1720 Revenue
Standard Chemical & Pharmaceutical had revenue of 1.83B TWD in the quarter ending June 30, 2025, with 3.85% growth. This brings the company's revenue in the last twelve months to 6.88B, up 4.12% year-over-year. In the year 2024, Standard Chemical & Pharmaceutical had annual revenue of 6.79B with 8.81% growth.
Revenue (ttm)
6.88B
Revenue Growth
+4.12%
P/S Ratio
1.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.79B | 549.46M | 8.81% |
| Dec 31, 2023 | 6.24B | 388.40M | 6.64% |
| Dec 31, 2022 | 5.85B | 1.25B | 27.09% |
| Dec 31, 2021 | 4.60B | 298.68M | 6.94% |
| Dec 31, 2020 | 4.31B | 368.27M | 9.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.67B |
| Sunmax Biotechnology | 1.95B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |